Intrauterine Vascular Growth Retardation in 150 Cases at Ehs Nouar Fadela: Preliminary Results


  •   Bouabida Djamila

  •   Zelmat Setti Aouicha

  •   Belalaoui Izdihar


Intrauterine growth retardation represents the third cause of neonatal morbidity and mortality after prematurity and malformations. This pathology is a real public health problem.

Objectives: To determine the epidemiological profile of IUGR newborns, their morbidity and mortality, their immediate fate and to evaluate the correlation between certain maternal parameters and IUGR.

Methods: This is a descriptive and analytical study conducted between January 2012 and January 2014, the results were processed on software 3.5.3 Epi info.

Results: We recorded 8114 deliveries including 150 newborn IUGR cases, representing 1.8% of births. For the maternal characteristics: the average age was 31 ±6.7 years. The percentages of pre-eclampsia, gravidic hypertension and chronic hypertension were found respectively in 60%, 31.3% and 4.7% of the pregnant women. Prematurity was noted in 82.1% with an average gestational age of 35.2 ±2.7 years. 86% of the cases were extracted by the high route right away. Neonatal complications were dominated by perinatal asphyxia (5%), hypoglycaemia (4%) and respiratory distress (2%).

Conclusion: Efforts remain to be made in terms of screening, prenatal consultations and management of pregnant women with IUGR in order to improve the neonatal prognosis.

Keywords: Growth retardation, hypertension, hypoglycemia


Imdad A, Yakoob MY, Siddiqui S, Ahmed Z. Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduction of IUGR related stillbirths. BMC Public Health. 2011; 11(Suppl 3): S1.

Catov JM, Nohr EA, Olsen J, Ness RB. Chronic hypertensionrelated to risk forpreterm and term small for gestationalage births. Obstet Gynecol. 2008; 112: 290-6

Odibo AO, Nelson D, Stamilio DM, Sehdev HM, Macones GA. Advanced maternal age is an independent risk fac-tor for intrauterine growth restriction. Am J Perinatol. 2006; 23: 3258.

Beard JR, Lincoln D, Donoghue D, Taylor D, Summerhayes R, Dunn TM, et al. Socioeconomic and maternal determinants of small-for-gestational age births: patterns of increasing disparity. Acta Obstet Gynecol Scand. 2009; 88: 575-83.

Rakotozanany L. Facteurs relatifs au faible poids de naissance au CHUA gynécologie-obstétrique de Béfelatanana. Mémoire pour l’obtention de diplôme d’tudes spéciales de santé publique. 2004; 103: 51. French.

Boulaid L. Prise en charge du retard de croissance intra-uterin. A propos de 35 cas. M. S. Thesis, CHU Hassan II University 2011. French.

Howarth C, Gazis A, James D. Associations of Type 1 diabetesmellitus, maternal vascular disease and complications of pregnancy. Diabet Med. 2007; 24: 1229-34.

Kanda E, Matsuda Y, Makino Y, Matsui H. Risk factors associated with altered fetal growth in patients with pre-gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2012; 25: 1390-4.

Shah PS, Knowledge Synthesis Group on Determinants of LBW/PT births. Parity and low birth weight and preterm birth: a systematic review and meta‐analyses. Acta Obstetricia et Gynecologica Scandinavica. 2010; 89(7): 862-75.

Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, Group PC. Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet. 2007; 369: 17918.

Kabore P, Donnen P, Dramaix M. Facteurs de risque obstétricaux du petit poids de naissance à terme en milieu rural sahélien. Santé Publique. 2007; 19(6): 489-97. French.

Han Z, Mulla S, Beyene J, Liao G, McDonald SD. Maternal underweight and the risk of pretermbirth and low birth weight: a systematic review and meta-analyses. Int J Epidemiol. 2011; 40: 65-101.

Gardosi J, Francis A. Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles. Am J Obstet Gynecol. 2009; 201: 28e1-8.


How to Cite
Djamila, B., Aouicha, Z. S., & Izdihar, B. (2022). Intrauterine Vascular Growth Retardation in 150 Cases at Ehs Nouar Fadela: Preliminary Results. European Journal of Clinical Medicine, 3(4), 14–16.